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Objective : 
An important factor determining the choice of antibiotic for TRUS-Bx prophylaxis and 
treatment of post-biopsy infection is the prevalence of quinolone-resistant and ESBL-
producing organisms in the rectum of patients undergoing this procedure. We aim to 
determine these prevalence values in patients undergoing TRUS-Bx and to study their 
correlation with the microbiological data of patients with post-biopsy sepsis. 
 
Patients & Methods: 
From August 2011, rectal swabs were taken from patients undergoing TRUS-Bx in 
CMC and PMH before being given ciprofloxacin prophylaxis. Swabs were processed 
in selective media for ciprofloxacin-resistant and ESBL-producing organisms. Patients 
were prospectively studied for post-biopsy complications.  
 
Results: 
Of the 40 patients who had rectal swabs taken, 16(40%) and 17(42.5%) harbored 
ciprofloxacin-resistant and ESBL-producing coliforms respectively whilst ICBL-
producing coliform was found in one patient. A total of 32 bacterial colonies had their 
antibiogram studied. Among the broad-spectrum antibiotics, amikacin, Tienam®, and 
meropenem were 100% sensitive whilst sensitivity to Sulperazone® and Tazocin® both 
reached 96.9%. Resistance towards Augmentin®, ciprofloxacin, gentamicin, 
ceftriaxone, cefuroxime and Timentin® were 9.4%, 56.2%, 43.8%, 62.5%, 65.6%, 
and 3.1% respectively. 
 
Conclusions: 
A relatively high prevalence of ciprofloxacin-resistant and ESBL-producing coliforms 
was found in our TRUS-Bx patients, as compared to overseas data (10-22%). To our 
knowledge, this is the first study on antibiotic resistance in rectal flora of Asian 
patients undergoing TRUS-Bx. 
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